Low serum carnosine dipeptidase-1 (CNDP1) gene polymorphism protects patients with T2D against diabetic complications including nephropathy and can be allosterically blocked by the injection of reduced glutathione (GSH), N-acetylcysteine, and cysteine in diabetic mice [78]. The gene discussed is CNDP1; the disease is kidney disorder.